Episurf Medical AB (publ) (STO:EPIS.B)
Sweden · Delayed Price · Currency is SEK 0.0570
+0.0011 (1.97%)
Jul 24, 2026, 5:24 PM CET
Episurf Medical AB Balance Sheet
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 12.2 | 2.4 | 50.5 | 57.9 | 155.3 | 237.9 |
Cash & Short-Term Investments | 12.2 | 2.4 | 50.5 | 57.9 | 155.3 | 237.9 |
Cash Growth | 114.03% | -95.25% | -12.78% | -62.72% | -34.72% | 53.48% |
Accounts Receivable | 7.3 | 2.5 | 2.2 | 1.4 | 1.9 | 1.6 |
Other Receivables | 1.5 | 0.5 | 1.3 | 0.5 | 0.9 | 1.6 |
Total Trade Receivables | 8.8 | 3 | 3.5 | 1.9 | 2.8 | 3.2 |
Inventory | 2.7 | 0 | 3.2 | 3.7 | 1.9 | 1.9 |
Other Current Assets | 17.9 | 0.2 | 2.6 | 1.5 | 1.1 | 1.3 |
Total Current Assets | 41.6 | 5.6 | 59.7 | 65 | 161 | 244.4 |
Net Property, Plant & Equipment | 542.2 | 321.5 | 5.6 | 11.2 | 13.4 | 6.5 |
Other Intangible Assets | 37.4 | 0 | 35.3 | 33.7 | 29.5 | 23.1 |
Goodwill | 22 | 0 | - | - | - | - |
Other Long-Term Assets | 350 | 0 | - | - | - | - |
Total Assets | 722 | 166.3 | 97.8 | 104.3 | 197.2 | 270.6 |
Accounts Payable | 55.2 | 1 | 3.2 | 6.1 | 4.4 | 5.9 |
Accrued Expenses | 10.2 | 3 | 6.7 | 6.4 | 6 | 4.9 |
Current Portion of Leases | 2.9 | 0 | 2.3 | 2.9 | 2.5 | 2.1 |
Other Current Liabilities | 53.9 | 171.4 | 1.6 | 1.9 | 1.8 | 1.4 |
Total Current Liabilities | 122.2 | 175.4 | 13.9 | 17.4 | 14.7 | 14.2 |
Long-Term Debt | 44.1 | 0 | 0 | 0.2 | 1 | 2.8 |
Long-Term Leases | 1.4 | 0 | 0 | 2.3 | 3.8 | 0.8 |
Total Long-Term Liabilities | 45.4 | 0 | 0 | 2.4 | 4.8 | 3.5 |
Total Liabilities | 167.6 | 175.4 | 13.9 | 19.8 | 19.5 | 17.8 |
Common Stock | - | - | 6.5 | 80.2 | 80.1 | 80 |
Additional Paid-in Capital | - | - | 832.6 | 684.8 | 684.8 | 684.4 |
Accumulated Other Comprehensive Income | - | - | -0.1 | -0.3 | -0.2 | -0.3 |
Retained Earnings | - | - | -755.2 | -680.2 | -587 | -511.3 |
Total Common Shareholders' Equity | - | - | 83.8 | 84.5 | 177.7 | 252.8 |
Shareholders' Equity | 554.4 | -9.1 | 83.8 | 84.5 | 177.7 | 252.8 |
Total Liabilities & Equity | 722 | 166.3 | 97.8 | 104.3 | 197.2 | 270.6 |
Total Debt | 48.4 | 0 | 2.3 | 5.4 | 7.3 | 5.7 |
Net Cash (Debt) | -36.2 | 2.4 | 48.2 | 52.5 | 148 | 232.2 |
Net Cash Growth | - | -95.02% | -8.19% | -64.53% | -36.26% | 54.29% |
Net Cash Per Share | -0.03 | 0.00 | 0.10 | 0.20 | 0.56 | 1.02 |
Book Value | - | 0 | 83.8 | 84.5 | 177.7 | 252.8 |
Book Value Per Share | - | - | 0.17 | 0.32 | 0.67 | 1.12 |
Tangible Book Value | -59.4 | 0 | 48.5 | 50.8 | 148.2 | 229.7 |
Tangible Book Value Per Share | -0.04 | - | 0.10 | 0.19 | 0.56 | 1.01 |